Esperion Therapeutics
ESPR
#6184
Rank
A$1.32 B
Marketcap
A$5.59
Share price
-1.85%
Change (1 day)
53.00%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.75. In 2024 the company made an earnings per share (EPS) of A-$0.35 an increase over its 2023 EPS that were of A-$3.19.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79126.7%
2024A-$0.35-89.15%
2023A-$3.19-40.28%
2022A-$5.35-62.87%
2021A-$14.4180.38%
2020A-$7.9950.14%
2019A-$5.32-53.18%
2018A-$11.367.41%
2017A-$10.58110.81%
2016A-$5.0247.35%
2015A-$3.410.89%
2014A-$3.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
A-$8.95 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.10-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$2.59-444.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$65.46-8,788.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.17-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.29-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA